These findings suggest that lower expression of LEPR (rather than higher expression as hypothesized) is an important indicator of more aggressive breast cancer, independent of race, BMI, and menopausal status, and might serve as an important biomarker associated with disparate outcomes, particularly among Black women. This evidence concerns the gene LEPR and breast cancer.